J&J accepts Carlyle's $4.15B bid for diagnostics unit

Johnson & Johnson (JNJ) has accepted Carlyle's (CG) $4.15B binding offer for J&J's Ortho-Clinical Diagnostics (OCD) business.

J&J accepted the proposal, which the private-equity firm made in January, after consultation with the relevant works councils and trade unions.

J&J expects the deal to close toward the middle of the year. (PR)

From other sites
Comments (3)
  • hman487
    , contributor
    Comment (1) | Send Message
    Defining their true market area of emphasis while eliminating those areas which don't fit into their future image of JNJ........remodeling and renovation of a very large business entity into a scaled down super functioning business model to deal with the next twenty years of life science and pharma......
    31 Mar 2014, 09:16 AM Reply Like
  • biochemist
    , contributor
    Comments (796) | Send Message
    Interesting move to sell off Ortho. I guess the margins were not great enough in selling diagnostic kits.
    31 Mar 2014, 11:17 AM Reply Like
  • Eric Chemist
    , contributor
    Comments (74) | Send Message
    $4Billion to put towards acquisitions to help their pipeline.
    4 Apr 2014, 03:23 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs